Dealmaking slows in health and biotech in 2016, but doesn’t disappear from Philadelphia scene

  • Jefferson CEO Dr. Stephen Klasko (left) and Kennedy CEO Joseph Devine

Dealmaking slows in health and biotech in 2016, but doesn’t disappear from Philadelphia scene

While not as robust as in recent years, local merger and acquisition activity was alive and well across all sectors in the health care industry this year as companies continued to follow the mantra that “bigger is better.”

View the full article on bizjournals.com (Subscriber Content only)

Article originally posted on December 28, 2016 by John George